LONDON - AstraZeneca has signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung cancer drugs.
LONDON - Reckitt Benckiser plans to spin off its heroin-addiction treatment in the next 12 months as sales slide under pressure from rival copycat versions of the drug. | Video
ZURICH - Swiss pharmaceutical group Novartis said the European Commission has approved its eyecare unit Alcon's Simbrinza treatment for glaucoma, a chronic, sight-threatening eye disease.
- Shares of AcelRx Pharmaceuticals Inc plunged nearly 28 percent in premarket trading, after the U.S. Food and Drug Administration rejected its pain drug device, Zalviso, late on Friday.
WASHINGTON - U.S. lawmakers on Monday said they were expanding their investigation of federal biosecurity lapses including problems at the Centers for Disease Control and Prevention that led to the mishandling of anthrax and bird flu pathogens.
FREETOWN - Sierra Leone's president visited the epicenter of an Ebola outbreak on Monday as West African leaders stepped up efforts to contain the spread of the deadly virus.
LAGOS - The Nigerian city of Lagos on Monday shut down and quarantined a hospital where a man died of Ebola in the first recorded case of the highly infectious disease in Africa's most populous country.
TEL AVIV - LabStyle Innovations Corp said on Monday it has received approval from Israel's Ministry of Health to sell its Dario smart meter for diabetes in Israel.
SHANGHAI - A leading U.S. meat supplier said on Monday that a Chinese unit at the center of a food safety scandal had issues that were "absolutely inconsistent" with the group's high standards.
SHANGHAI - An on-going internal investigation conducted by OSI Group LLC into its unit, the scandal-hit Chinese food supplier Shanghai Husi Food Co Ltd, has revealed that standards were below par.